{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:15:20Z","timestamp":1791396920306,"version":"4.3.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"AHSC AFP Innovation Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12881-016-0276-4","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T04:21:33Z","timestamp":1456546893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature"],"prefix":"10.1186","volume":"17","author":[{"given":"Stephanie M.","family":"Luco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Sell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin D.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Dyment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,27]]},"reference":[{"issue":"9","key":"276_CR1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/hmg\/5.9.1305","volume":"5","author":"J Guimera","year":"1996","unstructured":"Guimera J, Casas C, Pucharcos C, Solans A, Domenech A, Planas AM, et al. A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet. 1996;5(9):1305\u201310.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"276_CR2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/dbio.2002.0675","volume":"246","author":"B H\u00e4mmerle","year":"2002","unstructured":"H\u00e4mmerle B, Vera-Samper E, Speicher S, Arencibia R, Mart\u0131nez S, Tejedor F. Mnb\/Dyrk1A is transiently expressed and asymmetrically segregated in neural progenitor cells at the transition to neurogenic divisions. Dev Biol. 2002;246(2):259\u201373.","journal-title":"Dev Biol"},{"issue":"12","key":"276_CR3","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/cercor\/bhr362","volume":"22","author":"M Martinez de Lagran","year":"2012","unstructured":"Martinez de Lagran M, Benavides-Piccione R, Ballesteros-Yanez I, Calvo M, Morales M, Fillat C, et al. Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons. Cereb Cortex. 2012;22(12):2867\u201377.","journal-title":"Cereb Cortex"},{"issue":"13","key":"276_CR4","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4161\/cc.29104","volume":"13","author":"U Soppa","year":"2014","unstructured":"Soppa U, Schumacher J, Florencio Ortiz V, Pasqualon T, Tejedor F, Becker W. The Down syndrome-related protein kinase DYRK1A phosphorylates p27Kip1 and Cyclin D1 and induces cell cycle exit and neuronal differentiation. Cell Cycle. 2014;13(13):2084\u2013100.","journal-title":"Cell Cycle"},{"issue":"1","key":"276_CR5","first-page":"62","volume":"57","author":"Z Chettouh","year":"1995","unstructured":"Chettouh Z, Croquette MF, Delobel B, Gilgenkrants S, Leonard C, Maunoury C, et al. Molecular mapping of 21 features associated with partial monosomy 21: involvement of the APP-SOD1 region. Am J Hum Genet. 1995;57(1):62\u201371.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"276_CR6","first-page":"997","volume":"60","author":"N Matsumoto","year":"1997","unstructured":"Matsumoto N, Ohashi H, Tsukahara M, Kim KC, Soeda E, Niikawa N. Possible narrowed assignment of the loci of monosomy 21-associated microcephaly and intrauterine growth retardation to a 1.2-Mb segment at 21q22.2. Am J Hum Genet. 1997;60(4):997\u20139.","journal-title":"Am J Hum Genet"},{"issue":"5\u20136","key":"276_CR7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s004390050571","volume":"100","author":"O Bartsch","year":"1997","unstructured":"Bartsch O, Hinkel GK, Petersen MB, K\u00f6nig U, Bugge M, Mikkelsen M, et al. A large family with subtelomeric translocation t (18; 21)(q23; q22. 1) and molecular breakpoint in the Down syndrome critical region. Hum Genet. 1997;100(5\u20136):669\u201375.","journal-title":"Hum Genet"},{"issue":"5","key":"276_CR8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ajhg.2008.03.001","volume":"82","author":"RS M\u00f8ller","year":"2008","unstructured":"M\u00f8ller RS, K\u00fcbart S, Hoeltzenbein M, Heye B, Vogel I, Hansen CP, et al. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am J Hum Genet. 2008;82(5):1165\u201370.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"276_CR9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ajmg.a.33228","volume":"152","author":"H Fujita","year":"2010","unstructured":"Fujita H, Torii C, Kosaki R, Yamaguchi S, Kudoh J, Hayashi K, et al. Microdeletion of the Down syndrome critical region at 21q22. Am J Med Genet A. 2010;152(4):950\u20133.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"276_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000320113","volume":"1","author":"R Oegema","year":"2010","unstructured":"Oegema R, de Klein A, Verkerk AJ, Schot R, Dumee B, Douben H, et al. Distinctive Phenotypic Abnormalities Associated with Submicroscopic 21q22 Deletion Including DYRK1A. Mol Syndromol. 2010;1(3):113\u201320.","journal-title":"Mol Syndromol"},{"issue":"1","key":"276_CR11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajmg.a.33735","volume":"155","author":"T Yamamoto","year":"2011","unstructured":"Yamamoto T, Shimojima K, Nishizawa T, Matsuo M, Ito M, Imai K. Clinical manifestations of the deletion of Down syndrome critical region including DYRK1A and KCNJ6. Am J Med Genet A. 2011;155(1):113\u20139.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"276_CR12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1399-0004.2010.01544.x","volume":"79","author":"B Bon Van","year":"2011","unstructured":"Van Bon B, Hoischen A, Hehir\u2010Kwa J, de Brouwer A, Ruivenkamp C, Gijsbers A, et al. Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly. Clin Genet. 2011;79(3):296\u20139.","journal-title":"Clin Genet"},{"issue":"5","key":"276_CR13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejmg.2012.03.011","volume":"55","author":"A Valetto","year":"2012","unstructured":"Valetto A, Orsini A, Bertini V, Toschi B, Bonuccelli A, Simi F, et al. Molecular cytogenetic characterization of an interstitial deletion of chromosome 21 (21q22. 13q22. 3) in a patient with dysmorphic features, intellectual disability and severe generalized epilepsy. Eur J Med Genet. 2012;55(5):362\u20136.","journal-title":"Eur. J. Med. Genet."},{"issue":"12","key":"276_CR14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/jmedgenet-2012-101251","volume":"49","author":"JB Courcet","year":"2012","unstructured":"Courcet JB, Faivre L, Malzac P, Masurel-Paulet A, Lopez E, Callier P, et al. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy. J Med Genet. 2012;49(12):731\u20136.","journal-title":"J Med Genet"},{"issue":"6114","key":"276_CR15","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.1227764","volume":"338","author":"BJ O\u2019Roak","year":"2012","unstructured":"O\u2019Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science. 2012;338(6114):1619\u201322.","journal-title":"Science"},{"issue":"11","key":"276_CR16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jmedgenet-2014-102554","volume":"51","author":"C Redin","year":"2014","unstructured":"Redin C, Gerard B, Lauer J, Herenger Y, Muller J, Quartier A, et al. Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing. J Med Genet. 2014;51(11):724\u201336.","journal-title":"J Med Genet"},{"key":"276_CR17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/gim.2014.58","volume":"16","author":"A Iglesias","year":"2014","unstructured":"Iglesias A, Anyane-Yeboa K, Wynn J, Wilson A, Cho MT, Guzman E, et al. The usefulness of whole-exome sequencing in routine clinical practice. Genet Med. 2014;16:922\u201331.","journal-title":"Genet. Med."},{"key":"276_CR18","doi-asserted-by":"crossref","unstructured":"Van Bon B, Coe B, Bernier R, Green C, Gerdts J, Witherspoon K, Kleefstra T, Willemsen M, Kumar R, Bosco P. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID. Mol Psychiatry. 2016;21(1):126\u201332.","DOI":"10.1038\/mp.2015.5"},{"issue":"3","key":"276_CR19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejmg.2014.12.014","volume":"58","author":"L Ruaud","year":"2015","unstructured":"Ruaud L, Mignot C, Gu\u00ebt A, Ohl C, Nava C, H\u00e9ron D, et al. DYRK1A mutations in two unrelated patients. Eur J Med Genet. 2015;58(3):168\u201374.","journal-title":"Eur. J. Med. Genet."},{"key":"276_CR20","doi-asserted-by":"crossref","unstructured":"Bronicki LM, Redin C, Drunat S, Piton A, Lyons M, Passemard S, Baumann C, Faivre L, Thevenon J, Rivi\u00e8re J. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A. Eur J Med Genet. 2015;23(11):1482\u20137.","DOI":"10.1038\/ejhg.2015.29"},{"key":"276_CR21","doi-asserted-by":"crossref","unstructured":"Ji J, Lee H, Argiropoulos B, Dorrani N, Mann J, Martinez-Agosto JA, Gomez-Ospina N, Gallant N, Bernstein JA, Hudgins L. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies. Eur J Med Genet. \ufeff2015;23(11):1473\u201381.","DOI":"10.1038\/ejhg.2015.71"},{"issue":"7","key":"276_CR22","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/ajmg.a.37067","volume":"167","author":"J Richer","year":"2015","unstructured":"Richer J, Daoud H, Geier P, Jarinova O, Carson N, Feberova J, et al. Resolution of refractory hypotension and anuria in a premature newborn with loss\u2010of\u2010function of ACE. Am J Med Genet A. 2015;167(7):1654\u20138.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"276_CR23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.str.2013.03.012","volume":"21","author":"M Soundararajan","year":"2013","unstructured":"Soundararajan M, Roos AK, Savitsky P, Filippakopoulos P, Kettenbach AN, Olsen JV, et al. Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition. Structure. 2013;21(6):986\u201396.","journal-title":"Structure"},{"key":"276_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(08)60503-6","volume":"62","author":"W Becker","year":"1998","unstructured":"Becker W, Joost H. Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog Nucleic Acid Res Mol Biol. 1998;62:1\u201317.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"issue":"Pt 15","key":"276_CR25","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1242\/jcs.00618","volume":"116","author":"M Alvarez","year":"2003","unstructured":"Alvarez M, Estivill X, de la Luna S. DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly. J Cell Sci. 2003;116(Pt 15):3099\u2013107.","journal-title":"J Cell Sci"},{"key":"276_CR26","doi-asserted-by":"crossref","unstructured":"Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, Gudjonsson SA, Sigurdsson A, Jonasdottir A, Jonasdottir A, Wong WS, Sigurdsson G, Walters GB, Steinberg S, Helgason H, Thorleifsson G, Gudbjartsson DF, Helgason A, Magnusson OT, Thorsteinsdottir U, Stefansson K. Rate of de novo mutations and the importance of father's age to disease risk. Nature. 2012;488(7412):471\u20135.","DOI":"10.1038\/nature11396"},{"key":"276_CR27","doi-asserted-by":"crossref","unstructured":"Okamoto N, Miya F, Tsunoda T, Kato M, Saitoh S, Yamasaki M, Shimizu A, Torii C, Kanemura Y, Kosaki K. Targeted next-generation sequencing in the diagnosis of neurodevelopmental disorders. Clin Genet. 2015;88(3):288\u201392.","DOI":"10.1111\/cge.12492"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-016-0276-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T07:05:56Z","timestamp":1498287956000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2350\/17\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,27]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["276"],"URL":"https:\/\/doi.org\/10.1186\/s12881-016-0276-4","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,27]]},"article-number":"15"}}